At1g19525 Antibody

What is At1g19525 and why are antibodies against it important for plant research?

At1g19525 encodes Dynamin-Related Protein 2B (DRP2B) in Arabidopsis thaliana, a protein previously implicated in membrane trafficking that has been identified as a novel component of plant defense responses . DRP2B functions as a negative regulator of RbohD-dependent reactive oxygen species (ROS) production in response to pathogen-associated molecular patterns like flg22 . Antibodies against DRP2B are crucial research tools for studying:

• Plant innate immunity mechanisms

• Membrane trafficking in response to pathogens

• ROS signaling pathways in plants

• The interplay between membrane dynamics and defense responses

The ability to detect DRP2B protein specifically is particularly valuable since DRP2A and DRP2B share high amino acid sequence identity, making their individual detection challenging without specific antibodies .

What types of antibodies are available for detecting At1g19525-encoded protein?

While the search results don't mention specific commercial antibodies for At1g19525/DRP2B, research typically employs:

• Polyclonal antibodies: Often generated against peptide sequences specific to DRP2B

• Monoclonal antibodies: Providing higher specificity for distinct epitopes

• Affinity-purified antibodies: As mentioned in the literature, "affinity purified polyclonal peptide antibody (αDRP2) that detects both DRP2A and DRP2B proteins due to their high amino acid sequence identity"

When selecting an antibody, researchers should consider using antibody search engines and data repositories to find validated options for their specific application . These resources allow comparison of available antibodies from different vendors and access to validation data to determine suitability for specific experiments .

How can I verify the specificity of an At1g19525/DRP2B antibody?

Verification of antibody specificity is crucial, especially when studying proteins with high sequence similarity like DRP2A and DRP2B. Recommended validation approaches include:

• Western blot analysis with mutant controls: Compare protein detection in wild-type, drp2a and drp2b single mutants to confirm specificity. Published studies showed "single mutants of drp2a-1 (SALK_071036) or drp2b-2 (SALK_134887) accumulated significantly reduced levels of DRP2 proteins" when analyzed by immunoblot .

• Recombinant protein controls: Express recombinant DRP2B protein as a positive control.

• Cross-reactivity testing: Test against closely related proteins (particularly DRP2A) to assess potential cross-reactivity.

• Immunoprecipitation followed by mass spectrometry: To confirm the identity of the precipitated protein.

• siRNA or CRISPR knockdown validation: Confirm reduced antibody signal in samples with reduced target expression.

What are the optimal sample preparation methods for detecting At1g19525/DRP2B in different applications?

Sample preparation varies by experimental application:

For Western Blot/Immunoblot Analysis:

• Harvest five-to-six-week-old Arabidopsis leaves (as used in published studies)

• Grind tissue in liquid nitrogen

• Extract proteins using a buffer containing:

  • 50 mM Tris-HCl (pH 7.5)

  • 150 mM NaCl

  • 1% Triton X-100

  • Protease inhibitor cocktail

• Centrifuge at 14,000g for 15 minutes at 4°C

• Quantify protein concentration in the supernatant

• Separate proteins by SDS-PAGE and transfer to a membrane

• Block and probe with the DRP2B antibody

For Immunolocalization Studies:

• Fix plant tissue in 4% paraformaldehyde

• Embed in paraffin or resin

• Section tissue at 5-10 μm thickness

• Deparaffinize and rehydrate sections

• Perform antigen retrieval if necessary

• Block and incubate with primary DRP2B antibody

• Visualize using fluorescent secondary antibodies

How do experimental conditions affect DRP2B detection in pathogen response studies?

The detection of DRP2B during pathogen response experiments requires careful consideration of:

• Timing of tissue collection: DRP2B's role in early defense responses suggests optimal sampling times may be minutes to hours after pathogen treatment .

• Elicitation methods: Different elicitors affect DRP2B responses differently:

  • flg22 peptide treatment: Used for focused PAMP studies

  • Live bacterial inoculation (Pto strains): For more complex interactions

• Growth stage: Five-to-six-week-old leaves have been used successfully in published studies .

• Sample processing: Rapid processing is crucial to preserve protein modifications that may occur during signaling responses.

• Controls: Include both wild-type and drp2b mutant plants as positive and negative controls.

What are the best control samples to include when using At1g19525/DRP2B antibodies?

Proper controls are essential for interpreting antibody-based experiments:

• Genetic controls:

  • Wild-type Arabidopsis (Col-0): Positive control for normal DRP2B expression

  • drp2b knockout mutant (e.g., SALK_134887): Negative control

  • drp2a knockout mutant (e.g., SALK_071036): For distinguishing DRP2A/B signals

  • drp2b rbohD double mutant: For studying pathway interactions

• Technical controls:

  • Primary antibody omission: To assess non-specific binding of secondary antibody

  • Pre-immune serum (for polyclonal antibodies): To assess non-specific binding

  • Peptide competition: Pre-incubation of antibody with immunizing peptide to demonstrate specificity

  • Isotype control: Matching isotype antibody from same species

• Treatment controls:

  • Mock treatments (H₂O) versus elicitor treatments (flg22)

  • Time course samples to track dynamic responses

How can At1g19525/DRP2B antibodies be used to study protein-protein interactions in plant defense signaling?

At1g19525/DRP2B antibodies can be valuable tools for investigating protein-protein interactions in several advanced applications:

• Co-immunoprecipitation (Co-IP):

  • Use anti-DRP2B antibodies to pull down the protein complex

  • Identify interacting partners by mass spectrometry or Western blot

  • Compare interactions under normal and pathogen-challenged conditions

  • Particularly useful for investigating interactions with RbohD, which DRP2B negatively regulates

• Proximity Labeling:

  • Create fusion proteins of DRP2B with BioID or APEX2

  • Use antibodies to verify expression and localization of the fusion protein

  • Identify proteins in proximity to DRP2B during defense responses

• Bimolecular Fluorescence Complementation (BiFC):

  • Verify BiFC construct expression using antibodies

  • Confirm protein-protein interactions visualized by BiFC with Co-IP using DRP2B antibodies

• Yeast Two-Hybrid Validation:

  • Validate Y2H hits using Co-IP with anti-DRP2B antibodies

  • Compare interaction strength under different conditions

The importance of these approaches is highlighted by DRP2B's role as a negative regulator of RbohD-dependent ROS production, suggesting protein-protein interactions are critical to its function in defense signaling .

What experimental approaches can reveal DRP2B's spatiotemporal dynamics during pathogen challenge?

Understanding the spatiotemporal dynamics of DRP2B during pathogen challenge requires sophisticated imaging approaches:

• Live-Cell Imaging with Fluorescent Proteins:

  • Verify that fluorescent protein fusions maintain proper localization using anti-DRP2B antibodies

  • Track DRP2B redistribution following pathogen perception

  • Correlate with membrane dynamics and endocytosis

• Immunofluorescence Microscopy:

  • Use anti-DRP2B antibodies to localize endogenous protein

  • Compare localization before and after pathogen treatments

  • Co-localize with markers for different cellular compartments

• Super-Resolution Microscopy:

  • Employ STORM or PALM with antibody-based detection

  • Achieve nanoscale resolution of DRP2B dynamics

  • Visualize association with membrane microdomains

• Electron Microscopy:

  • Use immunogold labeling with anti-DRP2B antibodies

  • Precisely localize DRP2B at the ultrastructural level

  • Identify association with specific membrane structures

Time course experiments have revealed that DRP2B's role in regulating ROS production peaks around 40 minutes after bacterial treatment , suggesting this timepoint is critical for spatiotemporal studies.

How can At1g19525/DRP2B antibodies help investigate post-translational modifications during immune signaling?

Post-translational modifications (PTMs) often regulate protein function during immune signaling. At1g19525/DRP2B antibodies can be used to study these modifications:

• Phosphorylation Analysis:

  • Immunoprecipitate DRP2B using specific antibodies

  • Analyze phosphorylation status by:

    • Western blot with phospho-specific antibodies

    • Mass spectrometry to identify modified residues

  • Compare phosphorylation patterns before and after pathogen elicitation

• Ubiquitination Studies:

  • Perform immunoprecipitation with anti-DRP2B antibodies

  • Probe for ubiquitin by Western blot

  • Identify ubiquitination sites by mass spectrometry

  • Determine if ubiquitination affects DRP2B stability or function

• SUMOylation Analysis:

  • Similar approach to ubiquitination studies

  • May reveal regulation mechanisms of DRP2B activity

• Membrane Association Dynamics:

  • Fractionate cells into membrane and cytosolic components

  • Use antibodies to track DRP2B redistribution

  • Determine if PTMs affect membrane association

Given DRP2B's role in membrane trafficking , PTMs likely regulate its association with membranes and interaction with defense signaling components during pathogen challenge.

What are common challenges when using At1g19525/DRP2B antibodies and how can they be overcome?

Researchers face several challenges when working with At1g19525/DRP2B antibodies:

• Cross-reactivity with DRP2A:

  • Challenge: DRP2A and DRP2B share high sequence identity

  • Solution: Use drp2a and drp2b single mutants as controls to distinguish signals

  • Alternative: Develop epitope-specific antibodies targeting unique regions

• Low Signal-to-Noise Ratio:

  • Challenge: Nonspecific binding or weak specific signal

  • Solutions:

    • Optimize antibody concentration through titration

    • Extend primary antibody incubation time at 4°C

    • Try different blocking reagents (BSA, milk, commercial blockers)

    • Increase washing stringency or duration

• Inconsistent Results Between Experiments:

  • Challenge: Variable detection between replicates

  • Solutions:

    • Standardize protein extraction protocols

    • Control for plant growth conditions and developmental stage

    • Include loading controls appropriate for subcellular fraction

    • Consider lot-to-lot variability in antibodies

• Detecting Dynamic Changes:

  • Challenge: Capturing transient modifications or interactions

  • Solutions:

    • Implement careful time-course experiments

    • Use rapid tissue harvesting and processing

    • Include phosphatase inhibitors in extraction buffers

    • Consider crosslinking approaches for transient interactions

How should I analyze and interpret contradictory results in DRP2B localization or function studies?

When faced with contradictory results:

• Evaluate Experimental Conditions:

  • Different elicitors may trigger distinct DRP2B responses

  • DRP2B responds differently to flg22 versus live Pto bacteria

  • Timing of analysis is critical - early versus late responses

• Consider Genetic Background Effects:

  • Different Arabidopsis ecotypes may show variable responses

  • Confirm genotypes of all plant materials

  • Check for potential second-site mutations in mutant lines

• Assess Antibody Specificity:

  • Different antibodies may recognize different DRP2B epitopes or conformations

  • Antibodies may have different sensitivities to post-translational modifications

  • Confirm specificity using multiple approaches

• Reconcile Data Through Additional Experiments:

  • Use complementary techniques to address the same question

  • If immunolocalization and biochemical fractionation give different results, consider:

    • Potential artifacts of fixation

    • Sensitivity differences between methods

    • Dynamic equilibrium versus static snapshot

• Data Integration:

  • Create a model that accounts for seemingly contradictory observations

  • Consider DRP2B's dual roles in membrane trafficking and defense signaling

  • Incorporate time-dependent changes in localization and function

How do I accurately quantify DRP2B levels or modifications from immunoblot data?

Accurate quantification of immunoblot data requires rigorous methodology:

• Proper Sample Preparation:

  • Ensure equal protein loading (10-20 μg total protein per lane)

  • Validate protein concentration using multiple methods (Bradford, BCA)

  • Include concentration gradients to verify linear detection range

• Appropriate Controls:

  • Include wild-type and drp2b mutant samples

  • Use internal loading controls (e.g., actin, tubulin, or GAPDH)

  • For phosphorylation studies, analyze total DRP2B and phospho-DRP2B ratios

• Image Acquisition:

  • Use a digital imaging system with linear detection range

  • Avoid saturated pixels that prevent accurate quantification

  • Capture multiple exposures to ensure signal is in linear range

• Quantification Approach:

  • Use scientific image analysis software (ImageJ, ImageLab, etc.)

  • Normalize to loading controls

  • Background subtraction should be consistent across samples

• Statistical Analysis:

  • Perform experiments with at least three biological replicates

  • Apply appropriate statistical tests based on data distribution

  • Report both means and measures of variation

What are the key differences between using antibodies to study DRP2B in different plant species?

When extending DRP2B research from Arabidopsis to other plant species:

• Sequence Conservation Assessment:

  • Perform sequence alignment of DRP2B homologs across species

  • Determine if existing antibodies will recognize epitopes in target species

  • Consider developing new antibodies against conserved regions

• Validation Requirements:

  • Confirm specificity in each new species

  • Use heterologous expression systems to verify antibody recognition

  • Consider CRISPR-generated mutants as negative controls

• Extraction Protocol Optimization:

  • Adjust protein extraction buffers for species-specific challenges:

    • Higher secondary metabolite content may require PVPP or TCA precipitation

    • Different tissue types may require modified homogenization approaches

• Cross-Species Comparative Studies:

  • Ensure equal protein loading is truly comparable between species

  • Consider differences in DRP2B expression levels between species

  • Analyze subcellular distribution, which may vary between species

• Specialized Applications:

  • Some techniques like immunohistochemistry may require species-specific fixation protocols

  • Antibody dilutions and incubation conditions often need optimization for each species

While specific antibodies against Arabidopsis DRP2B have been used successfully , similar approaches could be applied to study DRP2B homologs in other species like those that have antibodies available for plant cell wall components, such as the anti-Rhamnogalacturonan I antibody that recognizes components from Arabidopsis, soybean, and peppergrass .

How can I optimize immunoprecipitation protocols for studying DRP2B protein complexes?

Optimizing immunoprecipitation (IP) for DRP2B requires careful consideration of:

• Lysis Buffer Composition:

  • Start with a gentle buffer to preserve protein-protein interactions:

    • 50 mM Tris-HCl (pH 7.5)

    • 150 mM NaCl

    • 0.5-1% NP-40 or Triton X-100

    • 1 mM EDTA

    • Protease inhibitor cocktail

  • Include phosphatase inhibitors for phosphorylation studies

  • Consider crosslinking agents for transient interactions

• Antibody Selection and Coupling:

  • Compare different anti-DRP2B antibodies for IP efficiency

  • Consider covalently coupling antibodies to beads to prevent co-elution

  • Optimize antibody-to-lysate ratios (typically 2-5 μg antibody per mg protein)

• Pre-clearing Step:

  • Include pre-clearing with protein A/G beads alone

  • Use IgG from the same species as the primary antibody

  • Balance removing non-specific binding versus losing specific interactions

• Incubation Conditions:

  • Test different temperatures (4°C is standard)

  • Optimize incubation time (2 hours to overnight)

  • Use gentle rotation to maintain bead suspension

• Washing Stringency:

  • Balance between removing non-specific binding and preserving interactions

  • Consider a gradient of washing buffers with increasing salt concentration

  • Test different detergent concentrations

• Elution Methods:

  • Compare denaturing (SDS, boiling) versus non-denaturing (peptide competition) elution

  • For mass spectrometry, consider on-bead digestion to minimize contaminants

What are the advantages and limitations of different detection methods for DRP2B in various experimental contexts?

Different detection methods offer unique advantages and limitations for studying DRP2B:

Western Blot/Immunoblot

• Advantages: Quantifiable, size verification, detects post-translational modifications

• Limitations: Loses spatial information, potential denaturation issues

• Best for: Measuring total protein levels, detecting modifications, comparing expression across samples

• Example application: Comparing DRP2B protein levels in wild-type versus mutants

Immunofluorescence Microscopy

• Advantages: Preserves spatial information, co-localization potential

• Limitations: Fixation artifacts, lower quantitative precision

• Best for: Subcellular localization, co-localization with interaction partners

• Example application: Tracking DRP2B redistribution during pathogen response

Flow Cytometry

• Advantages: High-throughput, single-cell resolution, quantitative

• Limitations: Loses spatial information, requires cell suspension

• Best for: Analyzing large populations, measuring protein levels in specific cell types

• Example application: Comparing DRP2B levels across different cell types

Chromatin Immunoprecipitation (ChIP)

• Advantages: Detects DNA-protein interactions

• Limitations: May not be relevant for membrane proteins like DRP2B

• Best for: Transcription factors and chromatin regulators

• Example application: Not typically applicable for DRP2B

Proximity Ligation Assay (PLA)

• Advantages: High sensitivity for protein-protein interactions in situ

• Limitations: Requires two antibodies against different proteins

• Best for: Confirming interactions in native cellular context

• Example application: Visualizing DRP2B-RbohD interactions during pathogen response

When selecting a detection method, consider the specific biological question and the limitations of each approach in the context of DRP2B's membrane association and dynamic regulation during plant defense responses .